Utility of PharmacoGenomics for Reducing Adverse Drug Effects

Recruiting

Utility of PharmacoGenomics for Reducing Adverse Drug Effects

Sponsor:

Companion Dx Reference Lab, LLC

Code:

NCT02081872

Conditions

Genetics of Drug Metabolism

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information

Trial information was received from ClinicalTrials.gov and was last updated on 2025-06-16. This information was provided to ClinicalTrials.gov by Companion Dx Reference Lab, LLC on 2015-10-08.